Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study

BACKGROUND: Conventional regimens for refractory idiopathic membranous nephropathy (IMN) still have limitations. Rituximab (RTX) has a good effect in the treatment of refractory IMN. However, whether RTX single or combined with immunosuppressive therapy is more effective and whether adverse events w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xian, Jiao, Sumin, Li, Shaomei, Li, Juan, Li, Pei, Song, Fang, Yan, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339845/
https://www.ncbi.nlm.nih.gov/pubmed/37260416
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2022-9-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339845/
https://www.ncbi.nlm.nih.gov/pubmed/37260416
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2022-9-7

Ejemplares similares